vomiting

Glenmark launches AKYNZEO IV for prevention of chemotherapy-induced nausea and vomiting

AKYNZEO IV, a fixed-dose combination of fosnetupitant (235mg) and palonosetron(0.25mg), will be available as a single-dose, ready-to-dilute IV injection Glenmark…